BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15277240)

  • 1. Role of interleukin-1 in prion disease-associated astrocyte activation.
    Schultz J; Schwarz A; Neidhold S; Burwinkel M; Riemer C; Simon D; Kopf M; Otto M; Baier M
    Am J Pathol; 2004 Aug; 165(2):671-8. PubMed ID: 15277240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice.
    Riemer C; Schultz J; Burwinkel M; Schwarz A; Mok SW; Gültner S; Bamme T; Norley S; van Landeghem F; Lu B; Gerard C; Baier M
    J Virol; 2008 Dec; 82(24):12464-71. PubMed ID: 18842729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of galectin-3 in prion infections of the CNS.
    Mok SW; Riemer C; Madela K; Hsu DK; Liu FT; Gültner S; Heise I; Baier M
    Biochem Biophys Res Commun; 2007 Aug; 359(3):672-8. PubMed ID: 17555713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 expression is correlated with abnormal prion protein accumulation in murine scrapie.
    Jin JK; Na YJ; Song JH; Joo HG; Kim S; Kim JI; Choi EK; Carp RI; Kim YS; Shin T
    Neurosci Lett; 2007 Jun; 420(2):138-43. PubMed ID: 17531384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice.
    Parker LC; Luheshi GN; Rothwell NJ; Pinteaux E
    Br J Pharmacol; 2002 May; 136(2):312-20. PubMed ID: 12010781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice.
    Labow M; Shuster D; Zetterstrom M; Nunes P; Terry R; Cullinan EB; Bartfai T; Solorzano C; Moldawer LL; Chizzonite R; McIntyre KW
    J Immunol; 1997 Sep; 159(5):2452-61. PubMed ID: 9278338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytic ceruloplasmin expression, which is induced by IL-1beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor.
    Kuhlow CJ; Krady JK; Basu A; Levison SW
    Glia; 2003 Oct; 44(1):76-84. PubMed ID: 12951659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for the mechanism of astrogliosis in prion disease.
    Hafiz FB; Brown DR
    Mol Cell Neurosci; 2000 Sep; 16(3):221-32. PubMed ID: 10995549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease.
    Felton LM; Cunningham C; Rankine EL; Waters S; Boche D; Perry VH
    Neurobiol Dis; 2005 Nov; 20(2):283-95. PubMed ID: 15886005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated prion disease in the absence of interleukin-10.
    Thackray AM; McKenzie AN; Klein MA; Lauder A; Bujdoso R
    J Virol; 2004 Dec; 78(24):13697-707. PubMed ID: 15564479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD.
    Pauwels NS; Bracke KR; Dupont LL; Van Pottelberge GR; Provoost S; Vanden Berghe T; Vandenabeele P; Lambrecht BN; Joos GF; Brusselle GG
    Eur Respir J; 2011 Nov; 38(5):1019-28. PubMed ID: 21622588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
    Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Situ Temporospatial Characterization of the Glial Response to Prion Infection.
    Michael AV; Greenlee JJ; Harm TA; Moore SJ; Zhang M; Lind MS; Greenlee MHW; Smith JD
    Vet Pathol; 2020 Jan; 57(1):90-107. PubMed ID: 31331254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis.
    Brito BE; O'Rourke LM; Pan Y; Anglin J; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2583-9. PubMed ID: 10509653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein.
    Zetterström M; Lundkvist J; Malinowsky D; Eriksson G; Bartfai T
    Eur Cytokine Netw; 1998 Jun; 9(2):131-8. PubMed ID: 9681388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.